COMPANY
Kivu Bioscience
Timeline
Upcoming milestones
- 2027-12 (ESTIMATED) · Phase 1 · A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors · NCT07545356
- Mar 31, 2028 (ESTIMATED) · Phase 1 · A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors · NCT07229313
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07229313 | A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors | Phase 1 | Recruiting | Nov 13, 2025 | Mar 31, 2028 (estimated) |
| NCT07545356 | A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors | Phase 1 | Recruiting | May 25, 2026 | 2027-12 (estimated) |